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Abstract
Background: To address the need for more effective genomics training, beginning in 2012 the Icahn School of
Medicine at Mount Sinai has offered a unique laboratory-style graduate genomics course, “Practical Analysis of Your
Personal Genome” (PAPG), in which students optionally sequence and analyze their own whole genome. We
hypothesized that incorporating personal genome sequencing (PGS) into the course pedagogy could improve
educational outcomes by increasing student motivation and engagement. Here we extend our initial study of the
pilot PAPG cohort with a report on student attitudes towards genome sequencing, decision-making, psychological
wellbeing, genomics knowledge and pedagogical engagement across three course years.
Methods: Students enrolled in the 2013, 2014 and 2015 course years completed questionnaires before (T1) and
after (T2) a prerequisite workshop (n = 110) and before (T3) and after (T4) PAPG (n = 66).
Results: Students’ interest in PGS was high; 56 of 59 eligible students chose to sequence their own genome.
Decisional conflict significantly decreased after the prerequisite workshop (T2 vs. T1 p < 0.001). Most, but not all
students, reported low levels of decision regret and test-related distress post-course (T4). Each year baseline
decisional conflict decreased (p < 0.001) suggesting, that as the course became more established, students
increasingly made their decision prior to enrolling in the prerequisite workshop. Students perceived that analyzing
their own genome enhanced the genomics pedagogy, with students self-reporting being more persistent and
engaged as a result of analyzing their own genome. More than 90% of respondents reported spending additional
time outside of course assignments analyzing their genome.
Conclusions: Incorporating personal genome sequencing in graduate medical education may improve student
motivation and engagement. However, more data will be needed to quantitatively evaluate whether incorporating
PGS is more effective than other educational approaches.
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Background
Seeking to address the growing gap between the demand
for genome sequencing and the supply of genomics pro-
fessionals with the necessary training [1–10], in 2012 a
multidisciplinary group of faculty at the Icahn School of
Medicine at Mount Sinai developed, and have offered
yearly since, a novel laboratory-style medical genomics
course, “Practical Analysis of Your Personal Genome”
(PAPG). The objective is to prepare future clinicians and
researchers to effectively employ next generation
sequencing (NGS) and, in particular, whole genome
sequencing (WGS), around which we expect genomic
medicine will ultimately converge. PAPG students
uniquely have the opportunity, if they so choose, to
sequence and analyze their own whole genome at no
cost to them [11]. The motivating hypothesis was that
for those students who desire to do so, the opportunity
to analyze their own genome would improve educational
outcomes by increasing their engagement with the
course pedagogy and their motivation to master the
complexity of genome analysis.
There are potential risks to accessing personal genome
sequencing (PGS) results, particularly in an educational
setting where distress could adversely impact the stu-
dent’s wellbeing and their learning [12–15]. The PAPG
course sequence and sequencing protocol [11] were de-
signed to promote informed decision-making, minimize
the potential for test-related distress and maximize the
educational value of incorporating PGS. To assess the
protocol for and impacts of incorporating PGS into
graduate genomics education, a companion research
study has evaluated students’ attitudes towards,
decision-making for, and the outcomes of incorporating
PGS into PAPG.
This manuscript expands upon previously reported
results from the initial PAPG student cohort (n = 19)
[16, 17]. In 2012, students’ baseline interest in sequen-
cing their own genome was high, but many students
expressed decisional conflict. Decisional conflict
decreased after a prerequisite workshop, “Introduction
to Human Genome Sequencing” (IHGS), that is part of
the PAPG informed decision-making protocol, indicating
that students perceived their decision as more informed
after completing this pre-decision preparatory course-
work [16]. Post-PAPG, most, but not all, of the 2012
students reported low levels of decision regret and test-
related distress [17]. In follow-up interviews, students
reported that the opportunity to analyze their own
genome positively contributed to their motivation and
engagement [17].
The PAPG course has been offered yearly since 2012
and is now an established component of multiple train-
ing programs. Here we report on the attitudes towards
genome sequencing, decision-making for PGS and
psychological and educational outcomes of the 110 stu-
dents enrolled in the 2013, 2014 and 2015 cohorts, com-
prising 59 students eligible to sequence their own
genome, and a new comparison group of 51 primarily
enrolled only in the prerequisite workshop. In these sub-
sequent years we employed expanded questionnaires
that incorporated a more relevant knowledge measure
and new quantitative measures of engagement. This
much larger cohort improves our understanding of the
impacts of incorporating PGS into genomics pedagogy
and represents one of the larger study cohorts to
undergo predispositional WGS in any setting, not just
education [18].
Our second aim was to evaluate changes between
course years as the course, and WGS more generally, have
become more established. Students in 2013-onwards had
one or more years to anticipate enrolling in the course
and contemplate the decision to sequence their own
genome or not. And with the increasing use of genome
sequencing in both research and clinical settings, students
are increasingly likely to have encountered this technology
prior to enrolling in the PAPG course sequence. We
hypothesized that students’ attitudes towards genome
sequencing and their decision-making for PGS would be
different by year as a result. This extended experience will
inform how we evaluate courses of this kind and suggest
trends that may also be observed among participants in
predispositional PGS in non-educational settings.
Methods
Study and course design
This was a quantitative longitudinal cohort study in
which an evolving set of anonymous questionnaires were
administered to students enrolled in the “Practical Ana-
lysis of Your Personal Genome” (PAPG) course, and
its prerequisite workshop “Introduction to Human Gen-
ome Sequencing” (IHGS), at the Icahn School of Medi-
cine at Mount Sinai in the years 2013, 2014 and 2015.
The study protocol, course design and approval process
are described in more detail in related publications [11,
16, 17]. In brief, questionnaires were administered at 4
time points: before (T1) and immediately after (T2)
IHGS, a two-day 15-h prerequisite workshop, and before
(T3) and immediately after (T4) the semester-length
PAPG course. The course sequence and study time line
is summarized in Additional file 1: Figure S1. Paper
questionnaires were administered in 2013 and transi-
tioned to the online SurveyMonkey service for 2014
onwards.
As described in related publications, the Institutional
Review Board at the Icahn School of Medicine at Mount
Sinai determined the sequencing component of PAPG to
not be research and this study (#12–1273) to be exempt
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under category 2 [11, 16, 17]. Electronic consent was ob-
tained from all participants at the beginning of each
survey.
PAPG was a required course for students in the Masters
of Science in Genetic Counseling program (MSGC) and
offered as an elective course to other graduate students,
medical students and clinical trainees. A maximum of 20
students per year enrolled in PAPG with the option to
obtain and analyze their own whole genome sequence.
We describe these students as “genome eligible”. Starting
in 2014, students could also enroll in PAPG without the
option to obtain their own genome. All PAPG students
were required to complete the prerequisite IHGS work-
shop. Additional seats in IHGS were opened to all
students, faculty and employees of Mount Sinai Medical
Center up to a maximum total enrollment of approxi-
mately 35 students per year. Thus approximately 15
students per year were not continuing onto PAPG and or
not eligible to obtain their own genome sequence (these
students knew that they would not be able to obtain their
own genome sequence when they enrolled); these partici-
pants, described as “genome ineligible”, serve as a com-
parison group for pre-test measures of interest, attitudes
and psychological wellbeing. Enrollment and response
rates are listed in Table 1; enrollment demographics are
described in Additional file 1: Table S3.
As shown in the course timeline in Additional file 1:
Figure S1 students make the decision to undergo whole
genome sequencing after T2 (before T3) and obtain their
genome sequence data (or a reference genome) after T3.
Thus the T1 and T2 time points are “pre-decision”, T3 is
“post-decision” but “pre-results” and T4 is “post-results”.
This timeline differs from the previously reported 2012
cohort who made their decision after T3 [16]. PAPG stu-
dents do not receive a report with a specific set of gen-
etic findings; instead they receive the raw sequencing
data and analyze it themselves in a structured way dur-
ing the course. Thus the only results they “receive” are
those they themselves generate. A student can choose to
obtain their genome data but not actually view the data.
As part of the course pedagogy PAPG students can
create optional exclusion regions that mask variant calls
in those genomic regions (described in more detail in
[11]). The number of students reporting using exclusion
regions, the time they reported spending analyzing their
genomic data and the kinds and number of genomic
findings they reported generating are described in the
Results section.
Measures
The questionnaires assessed students’ motivations for
choosing to (not) sequence their own genome, decision-
making, attitudes towards personal genome sequencing
inside and outside the classroom, psychological well-
being, actions, and self-rated and objectively measured
genomics knowledge. Decision-related variables were
assessed with the Decisional Conflict Scale (DCS) [19],
the Decision Regret Scale (DRS) [20] and the Satisfac-
tion with Decision Scale (SWD) [21]. Interests and atti-
tudes were assessed with measures adapted from
Ormond et al. [22] and measures developed for this
study [16, 17]. Depression was assessed with the 10-
question version of the Center for Epidemiologic Studies
Depression Scale (CES-D 10) [23], anxiety with the
short-form State-Trait Anxiety Inventory (STAI-6) [24]
and test-related distress with an adapted version of the
Multidimensional Impact of Cancer Risk Assessment
(MICRA) [25]. Actions, such as use of exclusions, were
assessed with questions developed specifically for this
study. Self-rated knowledge was assessed with a measure
adapted from the HealthSeq WGS study [26] and object-
ive knowledge with a novel multiple choice test devel-
oped for this study. A complete listing of all measures,
including any modifications to the published measure or
scoring method, is included in the Supplemental
Methods and Data [Additional file 1] along with copies
of the survey instruments [Additional files 2, 3 and 4].
Data analysis
All data analysis was performed using the R statistical
package version 3.2. Missing data was omitted. The Wil-
coxon signed-rank test was used to compare differences
Table 1 Enrollment and survey response rate by year and time point. The numbers of PAPG students enrolled without the option
to sequence their own genome are shown in parentheses
2013 2014 2015
IHGS Only IHGS + PAPG IHGS Only IHGS + PAPG IHGS Only IHGS + PAPG
Enrolled 19 19a 10 25 (5)b 15 22 (2)c
T1 15 (79%) 19 (100%) 10 (100%) 24 (96%) 10 (66%) 21 (95%)
T2 12 (63%) 16 (84%) 9 (90%) 23 (92%) 8 (53%) 19 (86%)
T3 N/A 17 (89%) N/A 24 (96%) N/A 18 (82%)
T4 N/A 15 (79%) N/A 21 (84%) N/A 17 (77%)
aTwo of these students dropped the course during the semester
bTwo of the students who enrolled without the option to obtain their genome dropped the course during the semester
cOne of the students who enrolled without the option to obtain their genome dropped the course during the semester
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between pairs of time points for ordinal data. Kendall’s
tau was used to evaluate bivariate correlations. Repeated
measures ANOVAs were performed with linear models.
The Kruskal-Wallis or Wilcoxon-Mann-Whitney test
(ordinal, for 3 and 2 years respectively) and Chi-square
test (categorical) were used to evaluate differences
between course years within a single time point. To
account for multiple hypothesis testing, p-values ≤0.001
were considered significant [27]. Effect sizes were com-
puted using r for ordinal data and ϕ for categorical data,
and were described using Cohen’s criteria of 0.1 for
small effect, 0.3 for medium effect and 0.5 for large
effect [28].
Results
Student characteristics
Table 1 summarizes enrollment and questionnaire
response rates for 2013–2015. Students who enrolled in
PAPG but were not eligible to sequence their own gen-
ome are shown in parentheses. Additional file 1: Table
S3 summarizes enrollments by student program and
background, e.g. MSGC or post-doctoral fellows.
Interest, motivations and decision-making before and
after prerequisite workshop
Across the three course years 56 of 59 eligible students
chose to sequence their own genome. Given the small
number of students who chose a reference genome, we
do not describe students’ choices by year or demograph-
ics to maximize the confidentiality of their choice.
Figure 1 shows students’ interest in sequencing their
own genome and decisional conflict (DCS), before (T1)
and after (T2) the prerequisite workshop by year and
genome eligibility. Additional file 1: Table S4 summa-
rizes the DCS subscales.
A significant decrease in decisional conflict in genome
eligible students was observed after completion of the pre-
requisite workshop, with the mean score after the pre-
requisite workshop for all years (and overall) at or less
than 25, the threshold associated with implementing a de-
cision [29]. For those students with a baseline DCS score
< 25 there is no significant change in DCS score after the
prerequisite workshop (Z = −0.42, p = 0.68, r = 0.06, n =
26), while for those students with a baseline DCS
score ≥ 25, there was a large effect (Z = −4.11, p = 2.3e-6,
r = 0.58, n = 25). Only one of 27 students with a baseline
DCS score < 25 had a T2 DCS score ≥ 25. Four students
in total had DCS scores ≥37.5 at T2, the threshold associ-
ated with feeling unsure about a decision [29].
Figure 1 suggests that there are differences in baseline
DCS scores (i.e. at T1) between years and also in the
change in DCS scores between T1 and T2. Performing a
repeated measures ANOVA, we observed significant nega-
tive effects for the course (F(1,48) = 16.6, p = 0.00017), and
a b
Fig. 1 Interest and decisional conflict before and after prerequisite course. Mean and 95% confidence interval for: a interest in sequencing own
genome, measured on a 1–5 scale from “No, definitely” to “Yes, definitely”, and b decisional conflict (DCS) across time point, course year and
eligibility to sequence own genome. Vertical axes show scale range. Wilcoxon-signed rank test between time points for all students is shown in
each panel. DCS in panel b is annotated with cutoffs associated with implementing a decision (< 25) and feeling unsure about a decision
(> 37.5) [29]
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course year (F(2,48) = 9.18, p = 0.00042), but not signifi-
cant effects for the interaction (F(2,48) = 2.08, p = 0.14).
These results suggest there is no significant difference in
the impact of the prerequisite workshop on decisional
conflict between course years.
To assess their motivations at T1 and T2, students
were asked to indicate their agreement or disagreement
with a set of statements about the potential benefits for
and concerns about sequencing and analyzing their own
genome. The results are summarized in Additional file 1:
Table S5 for genome eligible students. At baseline the
median student agreed that PAPG would be an oppor-
tunity to “get information that would help improve my
health” and that their own genome would help them
understand genetics concepts better. And the median
student strongly agreed that PAPG would be an oppor-
tunity to “get a service that I would not ordinarily get if
I had to pay full price”. The median student also agreed
that they were concerned that they “might get some re-
sults what would be disturbing”, but disagreed or were
neutral to the other proposed concerns.
While generally there was little significant change in
students’ concerns over the prerequisite workshop
among genome eligible students, we did observe a sig-
nificant decrease with medium effect size in agreement
with “I feel that I would be at a disadvantage to my
classmates if I did not undergo the testing” (Z = −3.35,
p = 0.00073, r = 0.33, n = 52). After the introductory
course, the median student disagreed with the state-
ments “I would be concerned that my professors would
know who took up the offer of testing and who did not”
and “I would be concerned that my classmates would
know who took up the offer of testing and who did not”,
with no students agreeing with the former.
Satisfaction with decision and decision regret
Figure 2 shows satisfaction with decision (SWD) before
(T3) and after (T4) PAPG by year for genome eligible
students. Mean (SD) scores on the Decision Regret Scale
(DRS) after PAPG (T4) were 6.46 (10.1) with a range of
0–35. Students were generally satisfied with their deci-
sion, with the mean SWD increasing after the PAPG
course (mean SWD at T4 was greater than 4.5 in all
years; the scale has a range of 1–5 where 5 indicates
high satisfaction). We did not observe a significant
relationship between DCS at T2 and SWD (τ = −0.26,
p = 0.037, n = 42) or DRS (τ = 0.29, p = 0.015, n = 43).
Impact of personal genome sequencing in PAPG
Analyses performed and genetic results obtained
Table 2 summarizes whether students who sequenced
their own genome used that data for all or some ana-
lyses, what self-defined important results they generated
in their analyses and with whom they discussed their
results. No significant differences were observed
between years for these measures. All respondents used
their genomic data for all analyses, with most respon-
dents (30, 88.2%) reporting that they received results
that were important to them. A small number of
students (4, 11.8%) indicated that they incorporated
exclusions into their analyses.
Test-related distress and psychological wellbeing
Figure 3a shows test-related distress (MICRA Distress
subscale) after PAPG (T4) for students who chose to
sequence their own genome. Mean (SD) MICRA
Distress subscale across all years was 2.45 (3.59) and did
not significantly differ between years (H(2) = 3.35,
p = 0.19, n = 43). There was not a significant rela-
tionship between DCS at T2 and test-related distress
at T4 (τ = 0.15, p = 0.21 n = 42).
Figure 3b and c shows measures of depression (CES-D
10 Dichotomous) and anxiety (STAI-6) across time
points by course year for students who chose to se-
quence their own genome. For context, depression and
anxiety measures at T1 and T2 for students who did not
sequence their own genome are also shown. The major-
ity of these students were enrolled only in the prerequis-
ite course, and a minority were enrolled in PAPG but
Fig. 2 Satisfaction with decision. Mean and 95% confidence interval
for satisfaction with decision (SWD) of genome eligible students
before and after PAPG by course year. Wilcoxon-signed rank test
between time points is shown
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ineligible to sequence their own genome or were eligible
but chose not to sequence their own genome. No signifi-
cant changes were observed between T3 and T4 for ei-
ther the depression (Z = 0.90, p = 0.37, r = 0.094 n = 46)
or anxiety measures (Z = 0.26, p = 0.80, r = 0.027 n = 47).
There was not a significant relationship between DCS at
T2 and depression at T4 (τ = −0.0026, p = 0.98 n = 43)
or anxiety at T4 (τ = −0.064, p = 0.56 n = 42).
Utility of PGS and perceived impact on student academic
engagement
Tables 3, 4 and 5 summarize students’ perception of the
utility of analyzing their own genome and the amount of
analyses students performed outside of course assign-
ments. Perception of utility was high at baseline and did
not significantly change over the course timeline. Stu-
dents who sequenced their own genome on average
agreed with the proposed educational benefits of analyz-
ing their own genome, particularly that they better
understood the patient experience and that they per-
formed greater number of and more thorough analyses.
Almost all students reported analyzing additional vari-
ants outside of course assignments, including those stu-
dents that did not analyze their own genome. For
example, as shown in Table 5 outside of course assign-
ments, the median student reported analyzing 6–10 add-
itional variants and reported spending an additional 2–5 h
analyzing their own genome.
Impact of courses on genomics knowledge and
application of learning
Table 6 summarizes self-reported application of know-
ledge gained in class in their research, clinical or other
professional activities as of the end of PAPG (T4). Most
students (83%) reported already applying what they
learned in class.
Table 7 summarizes self-assessed and objectively mea-
sured knowledge over the course timeline. The entire
course sequence (IHGS and PAPG) had a medium-to-
large positive effect on self-assessed understanding of
WGS (Z = 3.22, p = 0.0015, r = 0.38, n = 35) and a large
and significant positive effect on objectively measured
knowledge (Z = 4.40, p = 0.24e-7, r = 0.57, n = 30). Since
almost all PAPG students have chosen to sequence their
own genome, we cannot meaningfully compare changes
between those who did and did not sequence their own
genome. There was not a significant relationship
between test-related distress reported at T4 and object-
ive knowledge at T4 (τ = 0.16, p = 0.30, n = 28) or the
change in objective knowledge over PAPG (τ = −0.0040,
p = 0.98, n = 26) for students who chose to sequence
their own genome.
Table 2 Self-reported “important” genomic results identified by
students who analyzed their own genome, and with whom
students discussed their results for 2014–2015 at T4, post-course
(questions were not included in 2013 T4 questionnaire)
Use your genome for all analyses T4
All 34
Some 0
Exclude regions T4a
No 30
Yes 4
Receive any results felt were important T4b
Yes 30
No 2
Not sure 2
If yes, in which categories
Carrier status 18 (56%)
Pharmacogenomic 12 (38%)
Monogenic disease 15 (47%)
Physical traits 6 (19%)
Polygenic disease risk 9 (28%)
Ancestry 13 (41%)
Variant(s) of unknown significance 10 (31%)
Other 0
Discuss results with anyone T4c
Yes 29
No 4
Choose not to answer 1
If yes, whom (check all that apply)
Genetic counselor 5 (17%)
Physician or other health professional 4 (14%)
Mother 18 (62%)
Father 15 (52%)
Sibling 12 (41%)
Other family 6 (21%)
Friends 24 (83%)
Significant other 17 (59%)
Instructors 10 (34%)
Other 0
Course have impact on your family T4d
Yese 8
No 24
Not sure 2
aChi-square test of association with year was not significant: χ2
(1) = 0.016, p = 0.90
bChi-square test of association with year was not significant: χ2
(2) = 1.89, p = 0.39
cChi-square test of association with year was not significant: χ2
(2) = 0.92, p = 0.63
dChi-square test of association with year was not significant: χ2
(2) = 2.56, p = 0.28
eFree text responses to how course impacted family listed in
Additional file 1: Table S6
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Impact of course sequence on attitudes toward genome
sequencing
In general students’ responses to the attitudes state-
ments did not change significantly over the course
sequence (T4 vs. T1), with the exception of increased
agreement with the statements “I know enough about
genetics to understand the whole genome sequencing
results” (Z = 3.53, p = 3.4e-4, r = 0.35, n = 50) and “I
understand the risks and benefits of using/getting personal
whole genome sequencing done” (Z = 3.88, p = 6e-5,
r = 0.39, n = 50), and increased disagreement with
“Concerns about privacy/risks to privacy” is a reason
to not use your own genome in class (Z = −3.66, p = 1.6e-4,
r-0.44, n = 34). Additional file 1: Tables S8-S10 summarize
responses to the attitude measures. Responses to the above
statements at T4 did not significantly differ between years:
“I know enough…” (H(2) = 5.52, p = 0.063, n = 52); “I
understand the…” (H(2) = 5.28, p = 0.07, n = 52); and “Con-
cerns about privacy…” (Z = 2.21, p = 0.027, n = 36).
Discussion
The results reported here from the 2013–2015 PAPG
cohorts reinforce and extend our observations from the
initial 2012 cohort [16, 17]: students’ interest in sequen-
cing their own genome was high, students felt their deci-
sion was more informed after the prerequisite workshop,
and, at the completion of PAPG, most, but not all,
students who sequenced their own genome reported low
levels of decision regret and test-related distress. To the
instructors and investigators knowledge, no 2013–2015
students experienced a focused episode of test-related
distress like that reported by a 2012 student in response
to a variant of unknown significance in a gene associated
with adult-onset incompletely penetrant monogenic
disease [17].
Although personal genomes play a large role in PAPG,
homework and other course exercises are necessarily
designed around instructor-provided genomic data so
that there is a known correct answer and so that
a b c
Fig. 3 Test-related distress and psychological wellbeing by time point and year. Mean and 95% confidence interval for: a test-related distress
(MICRA Distress subscale) post-course (T4), b depression (CES-D 10 Dichotomous), and c anxiety (STAI 6) across time point and course year.
Individual scores on the MICRA Distress Subscale are shown in reduced opacity. For context, panels b and c also include reported depression and
anxiety at T1 and T2 of students who did not sequence their own genome (either by choice or because they were ineligible). Since so few
students at T3 and T4 could not or did not sequence their own genome, their data is not shown. The dotted line in panel b shows the cutoff for
clinically significant depressive symptoms on the CES-D 10 Dichotomous (≥ 4) [48]
Table 3 Mean (standard deviation) and range of Likert-scaled agreement with utility of analyzing your own genome (1-strongly
disagree to 5-strongly agree)
I think analyzing my own genome would be/was useful
T1 (n = 99) T2 (n = 86) T3 (n = 52) T4 (n = 49) Test (n = 47)a
Eligible to sequence own genome 4.39 (0.89)
1–5
4.20 (1.05)
1–5
4.44 (0.89)
1–5
4.61 (0.76)
1–5
Z = 1.78, r = 0.18
p = 0.80
Not eligible to sequence own genome 4.00 (1.02)b
1–5
3.97 (0.97)b
1–5
N/A N/A
a Wilcoxon-signed rank test between T4 and T1
b 45 students not eligible to sequence own genome responded at T1, and 36 at T2
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students aren’t required to “turn in” their own genomic
data. Thus in many respects students have a typical
pedagogical experience that includes the supervised,
team-based, genomic analysis they will later perform
professionally [30]. But they are then further exercising
those new skills analyzing their own genomes (albeit
more autonomously than would be the case in a clinical
setting). Students reported also performing most or all of
the same analyses on their own genomes, with a majority
of students reporting spending 2–5 or 5–10 additional
hours analyzing their genome outside of course exercises
and assignments. And most, but not all, students agreed
or strongly agreed that they were more persistent and per-
formed more, and more thorough, analyses because they
analyzed their own genomes. These quantitative data ex-
tends the pilot qualitative results from the 2012 PAPG co-
hort [17]. And these results are consistent with reports
from other courses incorporating personal genomic test-
ing (typically genotyping) in which students generally
report that personal genomic testing enhanced their learn-
ing and improved their understanding of genomic testing
and the patient experience [31–39].
We cannot, however, quantitatively determine whether
incorporating PGS improves educational outcomes. Both
self-assessed and objective measures of genomics know-
ledge increase after completing PAPG. However, since
almost all students have elected to sequence their own
genome, there is an insufficient comparison group to
meaningfully evaluate the differences between students
who did and did not sequence their own genome. And
the context of PAPG did not allow the study to be
implemented as a controlled randomized trial that could
assess causality. Additional data will be needed to quan-
titatively assess the pedagogical value of PGS in PAPG.
The prerequisite workshop is intended to both educate
and promote informed decision-making. As indicated by
the significant decrease in decisional conflict, students feel
that their decision was more informed after completing
the prerequisite workshop. And afterwards fewer students
were concerned that they would be at a disadvantage if
they did not sequence their own genome and none of the
respondents agreed that they were concerned that the fac-
ulty would know their choice. The educational setting cre-
ates additional potential for coercion; students could feel
pressured to sequence their own genome, directly or indir-
ectly, by the faculty or their peers. Ensuring that students
do not feel disadvantaged in choosing a reference genome
and do feel that their choice is private are both important
to mitigating the possibility of coercion. These results in-
dicate that the course design and sequencing protocol are
achieving the above, and that the instructors are effectively
communicating the protections that are in place.
We note students’ decisional conflict is higher both
at baseline and after the prerequisite workshop than
that reported by participants in HealthSeq pre-
dispositional PGS study (mean of 11.34 before and
5.94 after genomic counseling) [40]. This difference
Table 4 Mean (standard deviation) and range of Likert-scaled
agreement with engagement measures (1-strongly disagree to
5-strongly agree)
Because I used my genomea T4 (n = 34)b
I was more persistent in completing
assignments or analyses
4.24 (1.02)
1–5
I better understand the patient
experience
4.35 (0.81)
2–5
I learned useful health or personal
information
4.09 (0.93)
2–5
I better understand genetics concepts 3.94 (0.86)
2–5
I performed more analyses outside
of class
4.35 (0.81)
2–5
I was more thorough in my analyses 4.35 (0.92)
2–5
a Questions not in 2013 questionnaire
b Wilcoxon-Mann-Whitney test of association with year was not significant for
any statement
Table 5 The distribution of number of variants and the time students spent analyzing variants outside of course assignments
Variants analyzed
outside of
assignmentsa
Own Genomeb Ref. Genome Hours spent analyzing
genome outside of
assignmentsa
Own Genomec Ref. Genome
0 1 1 Less than 1 3 2
1–2 3 0 1–2 2 0
3–5 10 1 2–5 14 1
6–10 11 1 5–10 13 0
11–20 9 0 10–20 4 0
21–30 3 0 20–30 1 0
More than 30 1 0 More than 30 0 0
a Questions not in 2013 questionnaire
b Linear-by-linear association with year was not significant: Z = −0.49, p = 0.63
c Linear-by-linear association with year was not significant: Z = −0.62, p = 0.53
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could reflect the many differences between these co-
horts, including that the HealthSeq cohort is self-
selected (individuals would likely not enroll in that
study if they did not want genetic findings from
WGS) whereas approximately half of PAPG students
are required to enroll in the course, or that PAPG
students are more knowledgeable about WGS than
the general public. As more individuals obtain
predispositional PGS [18] we will develop a better
understanding of the correlates of informed decision-
making; that data will inform development of much-
needed best practices for genomic counseling of
ostensibly healthy individuals.
We observed student attitudes and outcomes to be
similar between course years, except at baseline. Baseline
interest increased and decisional conflict decreased each
year, that is students increasingly began the course with
more certainty in their decision to sequence their own
genome or not. Over the study period the course
became more established and students had one or more
years to anticipate enrollment and the decision to
sequence their own genome. Concurrently genome
sequencing became more widely used in both clinical
and research settings and thus students are more likely
to have already encountered this technology at baseline.
Thus we hypothesize that over time more of the
decision-making process takes place prior to enrolling in
the PAPG course sequence. And indeed we observed
that in 2014 and 2015 baseline mean decisional conflict
was below the threshold associated with implementing a
decision, and baseline average agreement with both “I
know enough about genetics to understand the WGS
results” and particularly “I understand the risks and
benefits of using/getting personal WGS done” increased
each year. These results suggest that courses like PAPG,
and perhaps predispositional PGS more generally, may
need to be evaluated over several years to determine
“steady-state” measures of decision-making.
Limitations for this study include: the single site; a lar-
ger but still small sample size with missing responses;
and the possibility for students under- or over-reporting
variables that may be critical or supportive of the course
design, respectively, out of concern for impacts on the
institution, instructors and the continued availability of
Table 7 Mean (standard deviation) and range of self- and objectively-assessed genetics and genomics knowledge across all students
and time points
Self-assessed knowledge T1 (n = 65) T2 (n = 57) T3 (n = 52) T4 (n = 52) Test (n = 35)a
Confidence 2.9 (1.1)
1–5
3.4 (0.9)
1–5
3.1 (1.0
1–5
3.6 (0.7)b
1–5
Z = 2.82, r = 0.37
p = 0.0041
Current understanding of genetics 4.17 (0.78)
2–5
4.09 (0.71)
2–5
4.31 (0.64)
3–5
4.19 (0.69)
3–5
Z = −0.30, r = 0.04
p = 0.99
Genetics knowledge compared to others 4.11 (0.89)
2–5
4.05 (0.66)
2–5
4.19 (0.66)
2–5
4.46 (0.58)
3–5
Z = 2.01 r = 0.24
p = 0.065
Current understanding of WGS 3.68 (0.87)
2–5
3.88 (0.71)
2–5
3.75 (0.74)
2–5
4.08 (0.65)
3–5
Z = 3.22, r = 0.38
p = 0.0015
Current WGS knowledge compared to others 3.86 (0.83)
2–5
3.95 (0.85)
2–5
3.92 (0.79)
2–5
4.42 (0.54)
3–5
Z = 3.13, r = 0.37
p = 0.0026
Objective knowledge T1 (n = 60) T2 (n = 53) T3 (n = 37) T4 (n = 33) Test (n = 30)a
Genomics test 2.5 (1.7)c
0–7
3.1 (1.5)
0–7
2.9 (1.7)
0–7
4.3 (1.8)d
1–9
Z = 4.40, r = 0.57
p = 9.24e-7
Confidence is reported on a 1–5 scale from “No confidence” to “High confidence”. Current understanding is reported on a 1–5 scale from “None” to “High”, while
knowledge compared is reported on a 1–5 scale from “Much less than others” to “Much more than others”. Test results are reported for paired comparison of T1
and T4. Total number of valid responses shown at each time point. The objective knowledge measure, range 0–10, was only included in 2014–2015
aWilcoxon-signed rank test between T4 and T1, and thus only including eligible students
bOnly 44 participants answered this question at T4
cWilcoxon-Mann-Whitney test of association with year was not significant: Z = −1.11, p = 0.27
d Wilcoxon-Mann-Whitney test of association with year was not significant: Z = −1.27, p = 0.21
Table 6 Application of knowledge gained in class from 2014 to
2015 reported at T4, post-course
Applied the knowledge gained in class Studentsa
Yes 31
No 5
Not sure 1
If yes, in what ways?
Using online databases 26
Computing skills 9
Variant interpretation 25
Communicating NGS capabilities and limitations 18
Genome analysis pipeline 9
Otherb 3
aChi-square test of association with year was not significant: χ2
(2) = 0.83, p = 0.66
b “Other” responses listed in Additional file 1: Table S7
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the course. The online questionnaires incorporated
themes from follow-up qualitative interviews with initial
2012 cohort [17], but necessarily would not have
captured all attitudes or outcomes that may have been
elicited in an interview. With a predicted rate of health-
relevant adult-onset monogenic disease variants on the
order of 1–5% [41–43], this study is not yet well
powered to detect distress, and impacts thereof, caused
by these rare variants. And since all impacts are self-
reported, students may have experienced test-related
distress but not reported it on the questionnaires or to
the course or study team. Where possible we utilized
validated and widely used measures that permit com-
parison to other cohorts and contexts. At present, how-
ever, there is no common, rigorously validated, measure
of genomics knowledge making it difficult to compare
PAPG to other educational approaches [44]. Developing
such a measure is a key area of future work. PAPG is a re-
quired course for approximately half of the students, co-
horts that are entirely self-selected (or entirely required)
may respond differently to PGS in an educational setting.
Conclusions
PAPG is one of several experiments in participatory
genomics pedagogy [44] that also include incorporating
personal genotyping [31–39, 45], analyzing cadaver
genomes in anatomy lab [46], and bench-top sequencing
[47]. At present, the cost and complexity of WGS are bar-
riers to implementing educational PGS more widely.
However, in the future we expect WGS to be widely avail-
able at low cost; thus the question of whether to
incorporate PGS into genomics education will be strictly
of the balance between the educational benefits and the
possible adverse effects [11]. Here we showed that: the
prerequisite workshop and associated materials promoted
more informed decision-making about PGS; most, but not
all students, reported low levels of decision regret and
test-related distress; and students reported being more en-
gaged and persistent as a result of sequencing and analyz-
ing their own genome as part of the course. We hope this
report about our multi-year experience incorporating PGS
into graduate-level genomics education will contribute to
the important ongoing discussion on how to most effect-
ively train the much-needed next-generation of genomics
professionals.
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